利德曼 (300289)

BEIJING LEADMAN BIOCHEMISTRY CO.,LTD.

ASZ

Tags

New QFII HoldingsCold Chain LogisticsPharmaceutical ManufacturingGene ConceptBiological VaccinesAssisted ReproductionRestructuring Proposals

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 54401.15
  • Circulating A-Shares(W): 54315.65
  • Earnings Per Share(RMB): -0.0131
  • Net Assets Per Share(RMB): 3.0422
  • Operating Revenue(W RMB): 25224.34
  • Total Profit(W RMB): -368.68
  • Net Profit Attributable to Parent(W RMB): -713.48
  • Net Profit Growth Rate(%): -765.83
  • Weighted Return on Equity(%): -0.4300
  • Operating Cash Flow Per Share(RMB): 0.0180
  • Undistributed Profit Per Share(RMB): 0.7817
  • Capital Reserve Per Share(RMB): 1.1228

2. Main Business

The main business covers:

  • Research, production, and sales of in vitro diagnostic reagents
  • Research, production, and sales of diagnostic instruments
  • Research, production, and sales of biochemical raw materials

3. Company Basic Information

  • Company Name: Beijing Leadman Biochemistry Co., Ltd.
  • Listing Date: 2012-02-16
  • Industry: Pharmaceutical Manufacturing
  • Address: No. 5 Xinghai Road, Beijing Economic-Technological Development Area, Beijing, China
  • Website: www.leadmanbio.com
  • Company Profile：The company was established through the overall change of Beijing Leadman Biochemistry Technology Co., Ltd. Based on an audit report, the company converted its net assets of RMB 81,586,099.01 as of June 30, 2009, into 72 million shares, with the shareholding ratio of each shareholder remaining unchanged before and after the change. The portion of net asset value exceeding the registered capital was recorded as the company's capital reserve. On July 21, 2009, the company completed the industrial and commercial change registration with the Beijing Administration for Industry and Commerce.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Guangzhou High-tech Zone Technology Holding Group Co., Ltd. General Legal Person 25213.32 46.42
2 Yongying CSI All Share Medical Devices ETF Fund 201.13 0.37
3 Abu Dhabi Investment Authority QFII 129.11 0.24
4 MORGAN STANLEY & CO.INTERNATIONAL PLC. QFII 123.17 0.23

5. Concept Sectors

  • Biological Vaccine
  • Gene Concept
  • Cold Chain Logistics
  • Assisted Reproduction
  • Continuous Loss
  • Restructuring Plan
  • QFII New Entry

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information